Elevation Oncology, Inc. (ELEV)

NASDAQ: ELEV · IEX Real-Time Price · USD

3.610

0.00 (0.00%)

At close: May 17, 2024, 4:00 PM

3.530

-0.080 (-2.22%)

After-hours: May 17, 2024, 6:42 PM EDT

Elevation Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	49.26	45.92	146.28	79.4	1.74
Short-Term Investments	33.85	44.36	0	0	0
Cash & Cash Equivalents	83.11	90.28	146.28	79.4	1.74
Cash Growth	-7.95%	-38.28%	84.24%	4463.22%	-
Other Current Assets	4.86	2.7	3.14	1.39	0.17
Total Current Assets	87.96	92.98	149.42	80.79	1.91
Property, Plant & Equipment	0.06	0.1	0.04	0.06	0
Other Long-Term Assets	1.07	1.09	0.03	0.07	0
Total Long-Term Assets	1.13	1.18	0.07	0.12	0
Total Assets	89.09	94.16	149.49	80.91	1.91
Accounts Payable	0.51	6.36	5.65	5.68	0.46
Other Current Liabilities	3.64	9.33	3.14	1.11	0.14
Total Current Liabilities	4.15	15.69	8.79	6.79	0.6
Long-Term Debt	30.14	29.44	0	0	0
Other Long-Term Liabilities	0	0	0.01	0.02	0
Total Long-Term Liabilities	30.14	29.44	0.01	0.02	0
Total Liabilities	34.28	45.13	8.8	6.8	0.6
Total Debt	30.14	29.44	0	0	0
Debt Growth	2.38%	-	-	-	-
Retained Earnings	-195.97	-150.27	-55.19	-23.15	-5.88
Comprehensive Income	0.01	-0.16	0	0	0
Shareholders' Equity	54.81	49.03	140.7	-23.08	-5.87
Net Cash / Debt	52.97	60.85	146.28	79.4	1.74
Net Cash / Debt Growth	-12.94%	-58.41%	84.24%	4463.22%	-
Net Cash Per Share	1.55	2.62	12.06	100.28	2.34
Working Capital	83.82	77.29	140.64	74	1.32
Book Value Per Share	1.61	2.11	11.60	-29.15	-7.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).